Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single Dose, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3103-11
Published May 7, 2014 · Recall initiated: November 21, 2013
Summary
FDA records drug Class I recall D-1268-2014, published May 7, 2014 and initiated November 21, 2013. Recalling firm: B. Braun Medical Inc; Status: Terminated; Reported quantity: 136,392 units; Lot: Lot# H2S725, H2S726, Exp 07/14; H3D724, Exp 11/14; H3E724, Exp 12/14; Lot# H3H507, Exp 01/15. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFAZOLIN SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFAZOLIN SODIUM
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Nationwide, Puerto Rico and Spain
- Lot
- Lot# H2S725, H2S726, Exp 07/14; H3D724, Exp 11/14; H3E724, Exp 12/14; Lot# H3H507, Exp 01/15
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. BraunJune 15, 2022
- FDACefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. BraunJune 15, 2022
- FDACefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog NumberMay 7, 2014
- FDACefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog NumberMay 7, 2014
- FDACeftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog Number 3153-11, ForMay 7, 2014
- FDA0.9 % Sodium Chloride Injection USP, 1000 mL, Catalog No. S4000-SS, Rx Only, Sterile, Single Dose Container, BMay 7, 2014
Questions about this recall
Was Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single Dose, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3103-11 recalled?
Yes. FDA published recall D-1268-2014 on May 7, 2014. Reported hazard: Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFAZOLIN SODIUM.